Cain, a novel physiologic protein inhibitor of calcineurin
about
Inhibition of calcineurin phosphatase activity by a calcineurin B homologous proteinCalsarcins, a novel family of sarcomeric calcineurin-binding proteinsMEF2C DNA-binding activity is inhibited through its interaction with the regulatory protein Ki-1/57CHP2 activates the calcineurin/nuclear factor of activated T cells signaling pathway and enhances the oncogenic potential of HEK293 cellsDirect association of the unique C-terminal tail of transmembrane AMPA receptor regulatory protein γ-8 with calcineurinCalmodulin-dependent protein kinase IV regulates nuclear export of Cabin1 during T-cell activation.Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-lifeIntegration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosisCholecystokinin activates pancreatic calcineurin-NFAT signaling in vitro and in vivoDeletion of calcineurin and myocyte enhancer factor 2 (MEF2) binding domain of Cabin1 results in enhanced cytokine gene expression in T cellsSyndecan-4 is essential for development of concentric myocardial hypertrophy via stretch-induced activation of the calcineurin-NFAT pathwayStructure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assemblyA conserved family of calcineurin regulators.Regulation of the phosphatase PP2B by protein-protein interactionsThe calcineurin-binding protein cain is a negative regulator of synaptic vesicle endocytosisCalcium regulates transcriptional repression of myocyte enhancer factor 2 by histone deacetylase 4Signal transduction and genes-to-behaviors pathways in psychiatric diseasesTargeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophyTargeted inhibition of calcineurin attenuates cardiac hypertrophy in vivoCalcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycleCalpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death.Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunitFK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injuryCalcium-dependent dephosphorylation of the histone chaperone DAXX regulates H3.3 loading and transcription upon neuronal activationRegulation of MEF2 transcriptional activity by calcineurin/mAKAP complexesThe novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.MEF2 is restricted to the male gonad and regulates expression of the orphan nuclear receptor NR4A1Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.Effects of serine/threonine protein phosphatases on ion channels in excitable membranes.The calcineurin-dynamin 1 complex as a calcium sensor for synaptic vesicle endocytosis.Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibers but not muscle growthA calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.The eukaryotic response regulator Skn7p regulates calcineurin signaling through stabilization of Crz1p.Calcium, calcineurin, and the control of transcription.Ca(2+)-dependent interaction between FKBP12 and calcineurin regulates activity of the Ca(2+) release channel in skeletal muscle.Roles of serine/threonine phosphatases in hippocampal synaptic plasticity.Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.Calcineurin and hypertrophic heart disease: novel insights and remaining questions.Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivoHeterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kappaB.
P2860
Q22010915-D3B4A4C8-27F3-4D5C-AF50-645687E21B92Q24290615-1A4CEE0D-D6AF-47CE-9284-4FF3AF5E0D23Q24301051-DD2F5660-8D78-4554-B0E8-3E580B513B27Q24315700-03C5E8F4-9B94-4E05-A681-B971A9B6FF6DQ24319854-E588EDF0-A069-454A-B436-5EFDEFA8478AQ24529566-9D35E86C-2A0E-408F-BE9B-249BD335D9E5Q24530214-31873896-ED3E-475E-B77E-551764DB0341Q24599847-DEB6DC8D-2E18-4248-9F56-38E329AB248DQ24671007-92300CD4-7DDB-47E8-9B90-44F9FA10ADE0Q24674634-3B54564A-75D8-4BD0-85E5-26E0C6ABBB9AQ27311486-DC629972-3B78-42B0-80B5-651C4163C42DQ27666773-79E332AA-DFED-4E2E-B4B1-F23FAF1A66E2Q27933946-BA31FFF2-7DF3-41BF-94E8-FB8EE6378C76Q28076325-AE26BD48-F6DF-42BF-81D0-FD4D81F7CDBFQ28142953-FB424112-BA23-4E77-910C-A3F730AAB866Q28145073-5044EA91-F132-4C1B-B875-97BEE14DD321Q28182063-C8C9E7E3-3E87-49BF-A737-6C36697EBDB1Q28343890-90BBB7B3-4D89-439A-A920-74B00FE0FAAAQ28360110-9CA64E91-FA85-485E-8479-21C7F2F2A25CQ28505525-35C6BB15-09A1-41E8-AEC8-19573557755FQ28564504-C86AA9AF-338D-4827-9A39-3F9711F6612AQ28568901-82BB5CB0-3E30-4057-BFEB-0C7C7A3F279FQ28580429-08B49BBA-EA20-418F-99CB-B14F7CDCE02EQ28586252-0CA8DB2A-7A9C-46F4-909E-3CCAD580D9F2Q28586669-A160DD51-781B-4A6F-9469-40D55D2DA224Q30318847-61B2CB9B-B95E-41E7-837A-300E12EACC3AQ33632052-D4E06669-BEAC-4F5B-976B-08C7D9ED918FQ33713890-BA0F4E0E-72F3-4B33-B169-5D035531B141Q33807200-67569FB6-B976-43CF-AACF-41D9B9B9C603Q33873071-F3705DF2-2403-47E1-B792-EFBFE97AC759Q33949126-DB38C434-BF16-4FAB-A6FD-828E637BD76FQ33965285-120CA3E4-6F54-44F5-815C-2A1C557CF1AFQ34080425-11875A0A-AF1F-4D97-935C-0E0230F57B5BQ34092392-CA09ACF5-C03F-4150-B20A-2F1F6BCE0779Q34179106-2853AF0D-6DBD-43F1-8480-3EE2C9CA2323Q34297126-411A537D-C81E-41E0-9565-608F54842748Q34470478-EA368015-1303-42B8-97B2-72854C52EEE3Q34581528-0D7929D1-CE87-485F-8073-140F0B88ED2BQ34727513-061298FA-C8C0-4B9E-A6D7-33CFB10B832DQ34835284-B56E248B-D58A-42DC-905D-D56027D61848
P2860
Cain, a novel physiologic protein inhibitor of calcineurin
description
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1998
@ast
im Juli 1998 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1998/07/17)
@sk
vědecký článek publikovaný v roce 1998
@cs
wetenschappelijk artikel (gepubliceerd op 1998/07/17)
@nl
наукова стаття, опублікована в липні 1998
@uk
name
Cain, a novel physiologic protein inhibitor of calcineurin
@ast
Cain, a novel physiologic protein inhibitor of calcineurin
@en
Cain, a novel physiologic protein inhibitor of calcineurin
@nl
type
label
Cain, a novel physiologic protein inhibitor of calcineurin
@ast
Cain, a novel physiologic protein inhibitor of calcineurin
@en
Cain, a novel physiologic protein inhibitor of calcineurin
@nl
prefLabel
Cain, a novel physiologic protein inhibitor of calcineurin
@ast
Cain, a novel physiologic protein inhibitor of calcineurin
@en
Cain, a novel physiologic protein inhibitor of calcineurin
@nl
P2093
P2860
P356
P1476
Cain, a novel physiologic protein inhibitor of calcineurin
@en
P2093
H. Wolosker
P. E. Burnett
S. Blackshaw
S. H. Snyder
P2860
P304
18325–18331
P356
10.1074/JBC.273.29.18325
P407
P577
1998-07-17T00:00:00Z